Recicort 20Ml

Target species Dogs and cats. Indications for use Otitis externa. Symptomatic treatment of seborrhoeic dermatitis of the auricle. Contraindications Do not use in case of hypersensitivity to corticosteroids, salicylic acid or to any of the excipients. Do not use in animals with perforated tympanic membrane, as the product may be ototoxic. Do not use in dogs with demodicosis. Special warnings for each target species For an effective treatment of otitis externa it is essential that the ear canal is meticulously cleaned and dried before first treatment to remove cerumen and/or exudate. Excess hair around the treatment area should be clipped if necessary. For an effective treatment of seborrhoeic dermatitis existing scale and or exfoliative debris should be removed. Hair surrounding or covering the lesions may need to be clipped to enable the veterinary medicinal product to reach the affected skin. Otitis externa and seborrhoeic dermatitis may be primary disorders, but can also occur as a result of underlying disorders or disease processes (e.g. allergic disorders, endocrine disorders, neoplasia). Furthermore, infections (bacterial, parasitic or fungal) commonly occur concurrently with seborrhoeic dermatitis or may complicate cases of otitis externa. Therefore it is essential to identify any underlying disease process and initiate specific treatment if considered necessary. Special precautions for use in animals The maximum dose that may be administered is 7 drops per kg body weight per day. The recommended treatment dose (8-10 drops per ear; once or twice daily) should not exceed 7 drops per kg body weight per day. Care should be taken not to exceed this amount, particularly when treating smaller animals or when both ears require treatment. In cases of otitis externa with an infectious component (bacterial, parasitic or fungal) specific treatment should be administered if considered necessary. Systemic corticosteroid effects are possible, especially when the product is ingested by licking. Oral ingestion (including licking) of the product by treated animals or animals having contact with treated animals should be avoided. Additional corticosteroid treatment should be used only according to the benefit/risk assessment of the responsible veterinarian. Use with caution in animals with suspected or confirmed endocrine disorders (i.e. diabetes mellitus; hypo- or hyper-thyroidism, hyperadrenocorticism etc.). Since glucocorticosteroids are known to slow growth, use in young animals (under 7 months of age) should be based on a benefit/risk assessment by the attending veterinarian and subject to regular clinical re-evaluations. Care should be taken to avoid contact with eyes. Do not apply the veterinary medicinal product on damaged skin. If hypersensitivity to any of the components occurs, the ear should be thoroughly washed. Special precautions to be taken by the person administering the veterinary medicinal product to animals This product contains triamcinolone acetonide, salicylic acid and ethanol and may be harmful to children after accidental ingestion. Do not leave the product unattended. In case of accidental ingestion seek medical advice immediately and show the package leaflet or label to the physician. This product may be irritating to skin or induce hypersensitivity reactions. People with known hypersensitivity to corticosteroids or salicylic acid should avoid contact with the product. Avoid skin contact with the product. Wear single-use impermeable gloves when handling the product including rubbing in the affected skin of the animal. If contact occurs, wash hands or exposed skin and seek medical advice in case of hypersensitivity reactions or if irritation persists. This product may be irritating to the eyes. Avoid contact with the eyes including hand-to-eye contact. If contact occurs, rinse with clean water. If eye irritation persists, seek medical advice and show the package leaflet or label to the physician. This product may be harmful to the unborn child. As the product can be absorbed through the skin, pregnant women and women of childbearing potential should not handle this product or restrain the animal during treatment and should avoid contact with the ears of the treated animal until at least 4 hours after the application. Treated animals should not be handled and children should not be allowed to play with treated animals until the application site is dry. It is recommended that recently treated animals should not be allowed to sleep with owners, especially children. Adverse reactions Prolonged and extensive use of topical corticosteroid preparations is known to trigger local and systemic effects, including suppression of adrenal function, thinning of the epidermis and delayed healing. In rare cases redness and skin scaling have been reported. The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports). Use during pregnancy and lactation The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Use only according to the benefit/risk assessment of the responsible veterinarian. Interactions No data available. Use of additional corticosteroid treatment only according to the benefit/risk assessment of the responsible veterinarian.
Vat Rate: 20%